Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits

Brain Research

Volumn 760, Issue 1-2, 1997, Pages 68-73

  Mazer, Carrie ^a   Muneyyirci, Jennifer ^a   Taheny, Kenneth ^a   Raio, Nicholas ^a   Borella, Alice ^a   Whitaker Azmitia, Patricia ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Hippocampus; Learning memory; Parachlorophenylalanine; S 100 ; Schizophrenia; Serotonin; Synaptogenesis

Indexed keywords

FENCLONINE; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROMODULIN; PROTEIN S 100; SEROTONIN; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CELL DENSITY; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; MAZE TEST; MEMORY; MICROTUBULE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SYNAPSE; SYNAPTOGENESIS;

ANIMALS; CELL COUNT; COGNITION; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NERVOUS SYSTEM DISEASES; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0030744239     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00297-7     Document Type: Article

References (37)

1. Arnold S.E., Lee V.M.-Y., Gur R.E., Trojanowski J.Q. Abnormal expression of two microtubule-associated proteins (MAP-2 and MAP-5) in specific subfields of the hippocampal formation in schizophrenia. Proc. Natl. Acad. Sci. 88:1991;10850.
2. B but not NGF, EGF, insulin or calmodulin functions as a CNS serotonergic growth factor. Brain Res. 516:1990;354.
3. 1A agonist and dexamethasone reversal of p-chlor-amphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 677:1995;181.
4. Caceres A., Busciglio J., Ferreira A., Steward O. An immunocytochemical and biochemical study of the microtubule associated protein MAP-2 during post-lesion dendritic re-modeling in the central nervous system of adult rats. Mol. Brain Res. 3:1988;233.
5. Cheng L., Hamaguchi K., Ogawa M., Hamada S., Okado N. PCPA reduces both monoaminergic afferents and nonmonoaminergic synapses in the cerebral cortex. Neurosci. Res. 19:1993;111.
6. Chubakov A.R., Gromova E.A., Konovalov G.V., Sarkisova E.F., Chumasov E.I. The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res. 369:1986;285.
7. Chubakov A.R., Tsyganova V.G., Sarkisova E.F. The stimulating influence of the raphe nuclei on the morphofunctional development of the hippocampus during their combined cultivation. Neurosci. Behav. Physiol. 23:1993;271.
8. Chubakov A.R., Gromova E.A., Konovalov G.V., Chumasov E.I., Sarkisova E.F. Effect of serotonin on the development of a rat cerebral cortex tissue culture. Neurosci. Behav. Physiol. 16:1986;490.
9. Donato R. Perspectives in S-100 protein biology. Cell Calcium. 12:1991;713.
10. Haring J.H., Hagan A., Olson J., Rodgers B. Hippocampal serotonin levels influence the expression of S100 beta detected by immunocytochemistry. Brain Res. 631:1993;119.
11. Haring J.H., Yan W. Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Soc. Neurosci. Abstr. 19:1993;673.
12. Heale V.R., Vanderwolf C.H. Dentate gyrus and olfactory bulb responses to olfactory and noxious stimulation in urethane anaesthetized rats. Brain Res. 652:1994;235.
13. Holmes G.L. Morphological and physiological maturation of the brain in the neonate and young child. J. Clin. Neurophysiol. 3:1986;209.
14. Kligman D., Marshak D. Purification and characteriztion of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. 82:1985;7136.
15. Lauder J.M. Hormonal and humoral influences on brain development. Psychoneuroendocrinology. 8:1983;121.
16. Lauder J.M. Ontogeny of the serotonergic system in the rat: Serotonin as a developmental signal. Ann. NY Acad. Sci. 600:1990;297.
17. Lepetit P., Touret M., Grange E., Gay N., Bobillier P. Inhibition of methionine incorporation into brain proteins after the systemic administration of p-chlorophenylalanine and L-5-hydroxytryptophan. Eur. J. Pharmacol. 209:1991;207.
18. Losonczy M.F., Song I.S., Mohs R.C., Mathe A.A., Davidson M., Davis B.M., Davis K.L. Correlates of ventricle size in chronic schizophrenia. II: Biological measures. Am. J. Psychiatry. 143:1986;1113.
19. Lui J.P., Lauder J.M. S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33:1992;248.
20. Masliah E., Terry R.D., Alford M., DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: An alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38:1990;837.
21. Muller C.M., Akhavan A.C., Bette M. Possible role of S-100 in glia-neuronal signalling involved in activity dependent plasticity in the developing mammalian cortex. J. Chem. Neuroanat. 6:1993;215.
22. Naruse I., Kato K., Asano T., Suzuki F., Kameyama Y. Developmental brain abnormalities accompanied with the retarded production of S-100 beta protein in genetic polydactyly mice. Dev. Brain Res. 51:1990;253.
23. Nyback H., Berggren B.M., Hindmarsh T., Sedvall G., Wiesel F.A. Cerebroventricular size and cerbrospinal fluid monoamine metabolites in schizophrenia patients and healthy volunteers. Psychiatry Res. 9:1983;301.
24. Okado N., Cheng L., Tanatsugu Y., Hamada S., Hamaguchi K. Synaptic loss following removal of serotoninergic fibers in newly hatched and adult chickens. J. Neurobiol. 24:1993;687.
25. Potkin S.G., Weinberger D.R., Linnoila M., Wyatt R.J. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles. Am. J. Psychiatry. 140:1983;21.
26. Roberts A.C., Robbins T.W., Everitt B.J., Muir J.L. A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience. 47:1992;251.
27. Shemer A.V., Azmitia E.C., Whitaker-Azmitia P.M. Dose-related effects of prenatal 5-MT on development of serotonin terminal density and behavior. Dev. Brain Res. 59:1991;59.
28. Tonkiss J., Galler J., Morgane P.J., Bronzino J.D., Austin-LaFrance R.J. Prenatal protein malnutrition and postnatal brain function. Ann. NY Acad. Sci. 678:1993;215.
29. Ueda S., Gu X.F., Naruse I., Whitaker-Azmitia P.M., Azmitia E.C. Neuro-glia neurotrophic interactions in the S-100 beta retarded mutant mouse (Polydactylyl Nagoya). Brain Res. 633:1993;275.
30. Van Woerkom A.E. The major hallucinogens and the central cytoskeleton: An association beyond coincidence? Towards subcellular mechanisms in schizophrenia. Med. Hypothes. 31:1990;7.
31. Waddington J. Schizophrenia: Developmental neuroscience and pathobiology. Lancet. 341:1993;531.
32. Whitaker-Azmitia P.M., Azmitia E.C. Stimulation of astroglial serotonin receptors produces media which regulates development of serotonergic neurons. Brain Res. 497:1989;80.
33. Whitaker-Azmitia P.M., Murphy R., Azmitia E.C. S-100 protein is released from astroglial cells by stimulation of 5-HT1a receptors. Brain Res. 528:1990;155.
34. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: Basis for developmental pharmacology. Pharmacol. Rev. 43:1991;533.
35. Whitaker-Azmitia P.M., Azmitia E.C. Autoregulation of fetal serotonergic neuronal development: Role of high affinity serotonin receptors. Neurosci. Lett. 67:1986;307.
36. Whitaker-Azmitia P.M., Borella A., Raio N. Serotonin depletion with PCPA in the adult rat causes loss of MAP-2 staining: A possible model of schizophrenia. Neuropsychopharmacology. 12:1995;269.
37. Whitaker-Azmitia P.M., Shemer A.V., Caruso J., Molino L., Azmitia E.C. Role of high affinity serotonin receptors in neuronal growth. Ann. NY Acad. Sci. 600:1990;847.